Quick Answer
Evolent Health, Inc. reported Earnings Per Share Diluted of $5.07 (loss) per share for the year ending 2025.
- Evolent Health, Inc. showed a decrease of -525.9% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Evolent Health, Inc.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2013 to 2025 (12 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 12 years of available data (2013 to 2025), Evolent Health, Inc.'s Earnings Per Share Diluted has declined by 612.1%.
- Historical annual values: Fiscal year 2025: $5.07 (loss) per share | Fiscal year 2024: $0.81 (loss) per share | Fiscal year 2023: $1.28 (loss) per share | Fiscal year 2022: $0.20 (loss) per share | Fiscal year 2021: $0.44 (loss) per share | Fiscal year 2020: $3.94 (loss) per share | Fiscal year 2019: $3.67 (loss) per share | Fiscal year 2017: $0.94 (loss) per share | Fiscal year 2016: $3.55 (loss) per share | Fiscal year 2015: $6.93 per share | Fiscal year 2014: $13.46 (loss) per share | Fiscal year 2013: $0.99 per share.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: